Page 5 - Co Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Co-Diagnostics (NASDAQ:CODX – Free Report) and CellaVision AB (publ) (OTCMKTS:CLVSF – Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability. Analyst Recommendations This is a breakdown of current recommendations for […]

Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating) saw a large decrease in short interest in the month of May. As of May 31st, there was short interest totalling 598,800 shares, a decrease of 17.2% from the May 15th total of 723,400 shares. Based on an average daily volume of 143,500 shares, the short-interest ratio is presently […]

Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating) – Stock analysts at HC Wainwright boosted their Q2 2023 earnings estimates for shares of Co-Diagnostics in a report issued on Monday, May 15th. HC Wainwright analyst Y. Chen now anticipates that the company will post earnings per share of ($0.24) for the quarter, up from their prior forecast […]

/PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...